US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.13

-0.2357-0.38%

Post-market: 61.130.00000.00%16:10 EDT

Volume:18.04K

Turnover:1.10M

Market Cap:270.19M

PE:20.00

High:61.34

Open:61.15

Low:60.74

Close:61.36

52wk High:64.10

52wk Low:39.36

Shares:4.42M

Float Shares:4.42M

Volume Ratio:0.28

T/O Rate:0.41%

Dividend:1.53

Dividend Rate:2.50%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million

Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million

Roivant Sciences - Brepocitinib Nda Approval and Launch in Dermatomyositis Expected by End of September 2026

THOMSON REUTERS

Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236

THOMSON REUTERS

Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers

Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million

Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million

Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

THOMSON REUTERS

Guardant Health is Maintained at Overweight by Morgan Stanley

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.

Revolution Medicines Inc Expected to Post a Loss of $1.98 a Share - Earnings Preview

Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80

THOMSON REUTERS

BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG

Jefferies Cuts Ipsen to 'underperform' on Somatuline Competition Risk

Tax Authorities Target Medical Device Firms Over Inflated Invoicing Practices, Recover Billions

Brightspring Health Services Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

BrightSpring Health selloff appears overdone, says Mizuho

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PTH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.1284,"timestamp":1788552000000,"preClose":61.3641,"halted":0,"volume":18036,"hourTrading":{"tag":"盘后","latestPrice":61.1284,"preClose":61.1284,"latestTime":"16:10 EDT","volume":8,"amount":488.542,"timestamp":1788552604895,"change":0,"changeRate":0,"amplitude":0.011451},"delay":0,"changeRate":-0.0038410080160876043,"floatShares":4420000,"shares":4420000,"eps":3.057033,"marketStatus":"Post-Mkt","change":-0.2357,"latestTime":"09-04 16:23:05 EDT","open":61.15,"high":61.34,"low":60.74,"amount":1099106,"amplitude":0.009778,"askPrice":61.68,"askSize":139,"bidPrice":60.5,"bidSize":5,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788566400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.3641,"sharesOutstanding":2480000,"nav":61.35956,"aum":274890828.8,"dividendRate":0.024975,"bidAskSpread":0.001745,"postHourTrading":{"tag":"盘后","latestPrice":61.1284,"preClose":61.1284,"latestTime":"16:10 EDT","volume":8,"amount":488.542,"timestamp":1788552604895,"change":0,"changeRate":0,"amplitude":0.011451},"volumeRatio":0.275535,"impliedVol":0.1181,"impliedVolPercentile":0.4683},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4420000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.275535,"shares":4420000,"dividePrice":1.5267,"high":61.34,"amplitude":0.009778,"preClose":61.3641,"low":60.74,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.1284,"committee":-0.930556,"eps":3.057033,"divideRate":0.024975,"volume":18036,"delay":0,"ttmEps":3.057033,"open":61.15,"prevYearClose":49.701,"prevWeekClose":61.0661,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.0661,"twentyDayClose":60.3556,"sixtyDayClose":48.9337},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657638191","title":"Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638191","media":"Reuters","labels":["shareholding","policyRegulatory","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638191?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:07","pubTimestamp":1786014430,"startTime":"0","endTime":"0","summary":"Roivant Q1 FY27 net loss widens to $290.61 million; revenue slips to $1.44 millionRoivant posted a GAAP net loss of USD 290.61 million, widening from USD 273.91 million a year earlier; GAAP loss per s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL9Ngwhl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,policyRegulatory,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","IDNA","BK4501","MRNA","PTH","ROIV","BK4139","MRNX","BK4007","BK4585","LGHT","BK4532","BK4533","BK4588","WDNA","GNOM","MRNY","BK4568","BK4534","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638810","title":"Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638810","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638810?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:01","pubTimestamp":1786014062,"startTime":"0","endTime":"0","summary":"BRIEF-Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 MillionAug 06  - Roivant Sciences Q1 revenue USD 1.442 million.Q1 net income USD -290.606 millionQ1 pretax profit USD -294.564 million vs. IBES estimate USD -243.7 millionQ1 basic EPS USD -0.26Q1 income from operations USD -365.993 million vs. IBES estimate USD -306.8 millionQ1 operating expenses USD 367.827 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXNPHVMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633601","title":"Roivant Sciences - Brepocitinib Nda Approval and Launch in Dermatomyositis Expected by End of September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633601?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA7TZ9FK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4139","ROIV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657899596","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236","url":"https://stock-news.laohu8.com/highlight/detail?id=2657899596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657899596?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:10","pubTimestamp":1786007401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44313L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","PTH","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","RVMD","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","IDNA","CANC","BBH","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE0009354923.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571976","title":"Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571976?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:01","pubTimestamp":1785967310,"startTime":"0","endTime":"0","summary":"Revolution Medicines publishes corporate deck outlining RAS(ON) inhibitor pipeline targeting RAS-driven cancersRevolution Medicines highlighted Phase 3 RASolute 302 data in previously treated metastat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL65Wkg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IDNA","BBH","LU0109394709.USD","LU0889565916.HKD","RVMD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","PTH","IE0002141913.USD","CANC","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657726576","title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657726576","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657726576?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:11","pubTimestamp":1785964302,"startTime":"0","endTime":"0","summary":"Guardant Health director Ian T. Clark disposes of common shares worth $2.25 millionGuardant Health director Ian T. Clark reported option exercises on Aug. 4, 2026, acquiring 9,088 common shares at USD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL7mNXxZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Ian T. Clark Disposes of Common Shares Worth $2.25 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","LU0889565916.HKD","HELX","PTH","BK4588","BK4196","LFSC","LU0320765992.SGD","GNMX","FFOX","GDOC","BK4535","EKG","GNOM","BK4551","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657576322","title":"Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657576322","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657576322?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:01","pubTimestamp":1785963706,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc. reports results for the quarter ended June 30 - Earnings SummaryRevolution Medicines, Inc.RVMD.OQreported a quarterly adjusted loss of $3.06 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4139","LU0109394709.USD","LU0320765992.SGD","PTH","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IDNA","IE00B2B36J28.USD","IE0009355771.USD","CANC","RVMD","IE0009354923.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657057882","title":"Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657057882","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657057882?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:17","pubTimestamp":1785961029,"startTime":"0","endTime":"0","summary":"Revolution Medicines Q2 FY26 net loss widens to $644.4 million; R&D expenses rise to $394.9 millionRevolution Medicines posted a GAAP net loss of $644.4 million for Q2 2026, widening from a $247.8 mil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL46m7gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4585","NDAQ","IE00BN0W2T93.GBP","LU0889565916.HKD","PBE","BBH","IE00B4R5TH58.HKD","BK4588","SG9999014039.USD","IE00B2B36J28.USD","IE00B64PRP62.GBP","RPRX","IE0002141913.USD","LU2210149790.SGD","IE00BFTCPJ56.SGD","BK4112","RVMD","IE0009354923.USD","SG9999014013.SGD","LU0314104364.USD","IE00BJT1NW94.SGD","BCDF","IHE","IE00BKPKM429.USD","LU0109394709.USD","LU2210150020.SGD","SG9999014021.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","PTH","LU2095319765.USD","IDNA","CANC","IE00BN0W2W23.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527610","title":"Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527610?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA9FY8WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IDNA","BBH","IE00BFTCPJ56.SGD","LU0889565916.HKD","RVMD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0009354923.USD","CANC","IE00BJT1NW94.SGD","PTH","BK4139","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556059","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556059?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:44","pubTimestamp":1785847440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0109394709.USD","BK4535","LU0320765992.SGD","PTH","BK4585","HELX","GH","LFSC","EKG","FFOX","GDOC","GNMX","BK4588","LU0889565916.HKD","GNOM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656753914","title":"Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2656753914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656753914?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:22","pubTimestamp":1785828122,"startTime":"0","endTime":"0","summary":"Guardant Health filed a universal shelf registration statement, allowing it to issue various securities in the future.\nThe filing gives the company flexibility to raise capital through debt, equity, or hybrid instruments as needed.\nThis development could be used to support future financing, potential acquisitions, or balance sheet adjustments.\n\nGuardant Health, listed as NasdaqGS:GH, now has formal flexibility to raise funds through a range of securities. The stock last closed at $158.83 and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","LFSC","BK4588","LU0320765992.SGD","FFOX","EKG","GH","PTH","BK4196","GNMX","GDOC","HELX","GNOM","BK4551","BK4585","BK4535","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588975","title":"Revolution Medicines Inc Expected to Post a Loss of $1.98 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588975","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588975?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:55","pubTimestamp":1785801305,"startTime":"0","endTime":"0","summary":"Revolution Medicines Inc <RVMD.OQ> expected to post a loss of $1.98 a share - Earnings PreviewRevolution Medicines IncRVMD.OQRVMD.Ois expected to  show a rise in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IDNA","BBH","LU0109394709.USD","LU0889565916.HKD","RVMD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","PTH","IE0002141913.USD","CANC","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656697372","title":"Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656697372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656697372?lang=en_us&edition=fundamental","pubTime":"2026-08-03 22:00","pubTimestamp":1785765628,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Guardant Health (GH) and Cardinal Health (CAH). Gu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-guardant-health-gh-and-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-guardant-health-gh-and-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0211328371.USD","LU1267930227.SGD","BK4588","GNMX","LU1983299246.USD","SG9999001440.SGD","LU0162691827.USD","LABU","GDOC","LU1880398554.USD","HCSG","XBI","LU0154236417.USD","LU0889566641.SGD","EKG","LU0320765992.SGD","CAH","LFSC","BK4175","LU1267930490.SGD","LU0072461881.USD","GNOM","LU0109394709.USD","LU0128526141.USD","BK4551","BK4196","HELX","LU0889565916.HKD","LU0310799852.SGD","BK4581","LU0792757196.USD","LU1880398471.USD","LU1267930813.SGD","PTH","BK4585","GH","LU0006061336.USD","BK4535","BK4137","LU0211327993.USD","LU1571399168.USD","LU0052756011.USD","LU0310800965.SGD","FFOX","LU0029874061.USD","LU0128525689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656648372","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656648372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656648372?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:50","pubTimestamp":1785765023,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BrightSpring Health Services, Inc. (BTSG), Monte Ros...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","BTSG","PTH","BK4196","LU2468319806.SGD","LU2324357040.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737143","title":"Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656737143?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:13","pubTimestamp":1785755617,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44016O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BTSG","LU2324357040.USD","LU2468319806.SGD","PSCH","PTH","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656322698","title":"BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2656322698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656322698?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:11","pubTimestamp":1785748260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTSG","LU2089984988.USD","LU2468319806.SGD","PSCH","LU2324357040.USD","BK4196","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656252843","title":"Jefferies Cuts Ipsen to 'underperform' on Somatuline Competition Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2656252843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656252843?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:00","pubTimestamp":1785740403,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk** Jefferies downgrades French pharma firm IpsenIPN.PAto \"underperform\" from \"neutral,\" citing  long-term risks to its Somatul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL6N4400DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","RVMD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","IDNA","LU0889565916.HKD","IE00BJT1NW94.SGD","CANC","IE0009355771.USD","IE0002141913.USD","LU0109394709.USD","BK4139","BBH","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164799308","title":"Tax Authorities Target Medical Device Firms Over Inflated Invoicing Practices, Recover Billions","url":"https://stock-news.laohu8.com/highlight/detail?id=1164799308","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164799308?lang=en_us&edition=fundamental","pubTime":"2026-08-01 16:30","pubTimestamp":1785573029,"startTime":"0","endTime":"0","summary":"China's tax authorities have intensified scrutiny on the medical device sector, launching a campaign against widespread invoice fraud and fabricated transactions. On July 28, 2026, the State...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","PTH","MEDX","BK1574","MDEV","LGHT","RSPH","IEIH","BK1100","09996","BK1583","HART","AGNG","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395031","title":"Brightspring Health Services Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395031","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395031?lang=en_us&edition=fundamental","pubTime":"2026-08-01 03:06","pubTimestamp":1785524803,"startTime":"0","endTime":"0","summary":"Brightspring Health Services Inc reports results for the quarter ended June 30 - Earnings SummaryBrightspring Health Services IncBTSG.OQreported quarterly adjusted earnings of 45 cents per share for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X2ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","LU2089984988.USD","LU2468319806.SGD","LU2324357040.USD","BTSG","PTH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656957543","title":"BrightSpring Health selloff appears overdone, says Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2656957543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656957543?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:50","pubTimestamp":1785523834,"startTime":"0","endTime":"0","summary":"Mizuho reiterated an Outperform rating and $86 price target on BrightSpring Health (BTSG), noting the stock is down sharply following Q2 results as...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/brightspring-health-selloff-appears-overdone-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/brightspring-health-selloff-appears-overdone-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","BK4207","LU2089984988.USD","PTH","LU2324357040.USD","BK4196","BTSG","PSCH","LU2468319806.SGD","MFG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}